Table of Contents
ISRN Pediatrics
Volume 2013 (2013), Article ID 574937, 6 pages
Research Article

Targeted versus Universal Neonatal Hearing Screening in a Single Egyptian Center

1Department of Pediatrics, Faculty of Medicine, Ain Shams University, Abbassya Square, Cairo 11381, Egypt
2Audiology Unit, ENT Department, Faculty of Medicine, Ain Shams University, Abbassya Square, Cairo 11381, Egypt
3Ministry of Health, Cairo, Egypt

Received 25 June 2013; Accepted 5 August 2013

Academic Editors: S. C. Aronoff and D. Hall

Copyright © 2013 Safaa S. Imam et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


Aim. To compare targeted neonatal hearing screening (TNHS) and universal neonatal hearing screening (UNHS) since many developing countries, including Egypt, implement selective screening for high-risk neonates. Methods. 150 neonates were assessed; 50 full terms consecutively admitted to the well-baby nursery and 100 neonates consecutively admitted to neonatal intensive care unit (NICU), Ain Shams University. Patients were further subdivided into high-risk group which included 50 neonates with multiple risk factors for hearing loss and low risk group which included 50 neonates with only one risk factor. Transient evoked otoacoustic emissions (TEOAEs) were used for hearing screening. Auditory brain response (ABR) was performed 3 months later for failed TEOAEs. Results. The most frequent risk factor was consanguinity (46%). In the well-baby population, 16% failed TEOAEs. In the NICU, 30% of the low risk and 38% of the high risk groups failed TEOAEs. Regarding ABR, failed results were 12%, 10%, and 8% in the high-risk, low-risk, and healthy groups, respectively. Conclusion. The use of TNHS would have missed 8% of neonates from the well-baby group who actually had PCHL (permanent congenital hearing loss). The use of UNHS would identify all cases with PCHL, allowing for early intervention and follow-up.